Fallopian Tube Cancer
Fallopian Tube Cancer develops in the tubes connecting the ovaries to the uterus.
It is a rare form of gynecologic malignancy, often detected incidentally during evaluation for abdominal pain, bloating, or abnormal bleeding. Early diagnosis is essential to improve survival and may involve surgery, chemotherapy, or targeted therapies.
Causes and Risk Factors of Fallopian Tube Cancer
The exact cause is not fully understood, though certain factors increase risk.
- Genetic mutations: BRCA1 and BRCA2 mutations significantly increase risk.
- Age: Mostly occurs in women over 50.
- Personal or family history: Previous ovarian or breast cancers elevate the risk.
Symptoms and Clinical Indicators
Symptoms are often subtle and non-specific.
- Abdominal or pelvic pain
- Abnormal vaginal bleeding or discharge
- Bloating or swelling: Persistent abdominal distension
- Changes in bowel or urinary habits
Treatment Strategies for Fallopian Tube Cancer
Treatment is individualized based on stage and patient health.
- Surgical management: Removal of affected tubes, ovaries, and sometimes the uterus.
- Chemotherapy: Systemic treatment to target cancer cells and prevent recurrence.
- Targeted therapy and follow-up care for advanced cases.
Why Choose Us for Fallopian Tube Cancer
CureU Healthcare provides a multidisciplinary gynecologic oncology team, advanced imaging, and personalized treatment planning for optimal outcomes.
Conclusion
Fallopian Tube Cancer is rare but treatable when detected early. CureU Healthcare ensures comprehensive, expert care tailored to each patient.
